Showing results (211-220 of 217) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2020
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma FactorsNia Adeniji, Vinodhini Arjunan, Vijay Prabhakar, et al.Hepatology (Baltimore, Md.)|March 4, 2020
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan CriteriaAni Kardashian, Sander S Florman, Brandy Haydel, et al.Annals of Surgery|June 28, 2017
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant ConsortiumVatche G Agopian, Michael P Harlander-Locke, Richard M Ruiz, et al.Annals of Surgery|March 15, 2019
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant ConsortiumJoseph DiNorcia, Sander S Florman, Brandy Haydel, et al.Annals of Surgery|September 10, 2021
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver TransplantationMichael K Turgeon, Shimul A Shah, Aaron M Delman, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant ConsortiumBenjamin V Tran, Dimitrios Moris, Daniela Markovic, et al.Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.Pageof 22